SHC
Sotera Health Co.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$15.94
+0.41%Price chart
Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3Nov 6
Key dataNov 6, 2026
Open$15.82
From 52W high−18.57%
Volume1.31M
Market cap$4.55B
P/E (TTM)26.4x
P/S (TTM)3.7x
Div yield—
Key dataNov 6, 2026
Open
$15.82
From 52W high
−18.57%
Volume
1.31M
Market cap
$4.55B
ValuationView details →
P/E (Fwd)
15.2x
EV/EBITDA
11.8x
P/E (TTM)
26.4x
RSI (14)
29.0
MomentumView details →
1D Return
+0.41%
YTD Return
−10.13%
SummaryUpdated Sep 1, 2026
Sotera Health Company (NASDAQ:SHC) is a mission-critical sterilization and laboratory testing services provider that went public in November 2020. Founded in 2017 and headquartered in Broadview Heights, Ohio, the company operates through three main business segments serving the medical device, pharmaceutical, and food industries. Sotera Health has achieved 19 consecutive years of revenue growth and plays an essential role in ensuring the safety and efficacy of medical products before they reach patients and consumers.
Similar companies
Latest newsMore news →
Sotera Health Co reaffirmed its full-year 2026 outlook for constant-currency net revenue growth of 5.25%–6.75% and Adjusted EBITDA growth of 5.75%–7.25%.3d agoSotera Health Co reported third-quarter 2026 net revenues up 4.4% year over year, net income of $58 million, Adjusted EBITDA up 3.9%, and Adjusted EPS of $0.29, up 12%.3d agoSotera Health announced that it plans to release its third-quarter 2026 financial results before the market opens on November 3, 2026.16d ago